| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |